Tenon Medical, Inc. Common Stock (TNON) is a publicly traded Healthcare sector company. As of May 21, 2026, TNON trades at $0.72 with a market cap of $7.78M and a P/E ratio of -0.41. TNON moved -0.74% today. Year to date, TNON is -24.91%; over the trailing twelve months it is -39.68%. Its 52-week range spans $0.64 to $5.85. Analyst consensus is buy with an average price target of $2.63. Rallies surfaces TNON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tenon Medical Posts 24% Q1 Revenue Growth to $37.8 M, Eyes European Expansion: Tenon Medical reported record Q1 2026 revenue of $37.8 million, up 24% year-over-year, driven by strong demand for its surgical instrumentation portfolio. Management disclosed plans to expand European distribution channels and increase R&D spending by 15% to accelerate minimally invasive device launches.
| Metric | Value |
|---|---|
| Price | $0.72 |
| Market Cap | $7.78M |
| P/E Ratio | -0.41 |
| EPS | $-1.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.85 |
| 52-Week Low | $0.64 |
| Volume | 644 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.94M |
| Net Income | $-12.56M |
| Gross Margin | 59.79% |
2 analysts cover TNON: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.63.